Sirolimus Tablets are indicated for various purposes including for coating coronary stent, treat lymphangioleiomyomatosis, and to prevent rejection of organ transplant. Sirolimus has chemical formula C51H79NO13 with molar mass of 914.172 g/mol. They are said to work by inhibiting T & B cell activation thus help in curing health condition. Sirolimus Tablets show excellent protein binding ability of about 92% with only 14% of bioavailability. They are metabolized in liver with elimination half life of 57 to 63 hours and is mostly excreted in feces. This medicine is available at reasonable rates in bulk for our trusted clients.
Cash in Advance (CID), Cash Advance (CA)
500 Per Month
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market
Other Products in 'Pharmaceutical Tablets' You May Like